HBK Investments’s Loxo Oncology, Inc LOXO Stock Holding History

HBK Investments’s Portfolio LOXO Stock Details LOXO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q3	–	Sell	-6,933	Closed	-$556K	–	1185
2017 Q2	$556K	Buy	+6,933	New	+$384K	﹤0.01%	698

Other funds holding LOXO

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Aisling Capital New York $45.3M AUM 15.24% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Adage Capital Partners Boston, Massachusetts $64.8B AUM 42.7% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $309B AUM 23.92% 1-Year Est. Return

Lord, Abbett & Co Jersey City, New Jersey $30.6B AUM 57.44% 1-Year Est. Return

HBK Investments's LOXO Position: Q3 2017 in Review

HBK Investments sold out of Loxo Oncology, Inc (LOXO) in Q3 2017, closing a stake of 6,933 shares — an estimated $556K sold.

HBK Investments first reported a position in LOXO in Q2 2017 and held it in 1 quarter. The position peaked at $556K in Q2 2017. 148 funds tracked by Wall St. Rank hold LOXO as of Q3 2017.

HBK Investments reported no remaining Loxo Oncology, Inc position as of Q3 2017 after selling out during the quarter.
HBK Investments sold 6,933 Loxo Oncology, Inc shares in Q3 2017, an estimated $556K.
HBK Investments first reported a position in Loxo Oncology, Inc in Q2 2017 and held it in 1 quarter.
HBK Investments's Loxo Oncology, Inc position peaked at $556K in Q2 2017.
148 funds tracked by Wall St. Rank held Loxo Oncology, Inc as of Q3 2017.

Based on HBK Investments's 13F filing for Q3 2017, filed 14 Nov 2017.